# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 17, "Am J Ophthalmol .", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasJournal> \"Am J Ophthalmol .\"."
1, PublicationYear, 18, 22, "2002", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasPublicationYear> \"2002\"."
3, Randomized, 52, 62, "Randomized", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
2, Title, 52, 157, "Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure .", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasTitle> \"Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure .\"."
4, Latanoprost, 81, 92, "latanoprost", "", 
5, Unoprostone, 97, 108, "unoprostone", "", 
6, IOP, 135, 155, "intraocular pressure", "", 
7, Author, 158, 167, "Jampel HD", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasAuthor> \"Jampel HD\"."
8, Author, 176, 187, "Bacharach J", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasAuthor> \"Bacharach J\"."
9, Author, 190, 197, "Sheu WP", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasAuthor> \"Sheu WP\"."
10, Author, 200, 207, "Wohl LG", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasAuthor> \"Wohl LG\"."
11, Author, 210, 219, "Solish AM", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasAuthor> \"Solish AM\"."
12, Author, 222, 232, "Christie W", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasAuthor> \"Christie W\"."
86, Latanoprost, 235, 246, "Latanoprost", "", 
87, Unoprostone, 249, 260, "Unoprostone", "", 
52, USA, 418, 421, "USA", "", 
13, ObjectiveDescription, 455, 682, "To compare the intraocular pressure ( IOP ) - lowering effect and safety of latanoprost 0 . 005 % once daily with that of unoprostone 0 . 15 % twice daily for patients with primary open - angle glaucoma or ocular hypertension .", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasObjectiveDescription> \"To compare the intraocular pressure ( IOP ) - lowering effect and safety of latanoprost 0 . 005 % once daily with that of unoprostone 0 . 15 % twice daily for patients with primary open - angle glaucoma or ocular hypertension .\"."
14, IOP, 470, 490, "intraocular pressure", "", 
15, IOP, 493, 496, "IOP", "", 
54, Latanoprost, 531, 542, "latanoprost", "", 
56, DoseValue, 543, 550, "0 . 005", "", 
59, Percentage, 551, 552, "%", "", 
60, Frequency, 553, 563, "once daily", "", 
55, Unoprostone, 577, 588, "unoprostone", "", 
57, DoseValue, 589, 595, "0 . 15", "", 
58, Percentage, 596, 597, "%", "", 
61, Frequency, 598, 609, "twice daily", "", 
89, Primary_OpenAngleGlaucoma, 628, 657, "primary open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_OpenAngleGlaucoma>."
16, OcularHypertension, 661, 680, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
62, Randomized, 692, 702, "Randomized", "", 
41657, Prospective, 735, 746, "prospective", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
63, Duration, 749, 757, "8 - week", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasCTduration> \"8 - week\"."
18, Blind, 760, 781, "investigator - masked", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
19, Parallel, 784, 792, "parallel", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
20, Multicenter, 820, 836, "numerous centers", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
53, USA, 844, 857, "United States", "", "<http://ctro/data#Population_107004> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
21, NumberPatientsCT, 860, 863, "165", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasNumberPatientsCT> \"165\"."
22, Precondition, 864, 950, "previously treated patients with IOP > or = 25 mm Hg in one or both eyes after washout", "", "<http://ctro/data#Population_107004> <http://ctro/data#hasPrecondition> \"previously treated patients with IOP > or = 25 mm Hg in one or both eyes after washout\"."
64, mmHg, 911, 916, "mm Hg", "", 
65, Randomized, 956, 964, "randomly", "", 
66, Latanoprost, 992, 1003, "latanoprost", "", "<http://ctro/data#Latanoprost_107043> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_107042> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_107043>."
68, DoseValue, 1004, 1011, "0 . 005", "", "<http://ctro/data#Medication_107042> <http://ctro/data#hasDoseValue> \"0 . 005\"."
70, Percentage, 1012, 1013, "%", "", "<http://ctro/data#Medication_107042> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
72, Frequency, 1014, 1024, "once daily", "", "<http://ctro/data#Intervention_107030> <http://ctro/data#hasFrequency> \"once daily\"."
23, Bedtime, 1032, 1039, "evening", "", "<http://ctro/data#Intervention_107030> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Bedtime>."
67, Unoprostone, 1043, 1054, "unoprostone", "", "<http://ctro/data#Medication_107049> <http://ctro/data#hasDrug> <http://ctro/data#Unoprostone>."
69, DoseValue, 1055, 1061, "0 . 15", "", "<http://ctro/data#Medication_107049> <http://ctro/data#hasDoseValue> \"0 . 15\"."
71, Percentage, 1062, 1063, "%", "", "<http://ctro/data#Medication_107049> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
73, Frequency, 1064, 1075, "twice daily", "", "<http://ctro/data#Intervention_107036> <http://ctro/data#hasFrequency> \"twice daily\"."
88, Mean, 1263, 1267, "mean", "", 
24, IOP, 1275, 1279, "IOPs", "", 
181, TimePoint, 1336, 1344, "baseline", "", 
182, TimePoint, 1376, 1383, "8 weeks", "", 
74, Mean, 1427, 1431, "mean", "", "<http://ctro/data#Mean_107070> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_107068> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_107070>."
46, IOP, 1448, 1452, "IOPs", "", "<http://ctro/data#IOP_107069> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_107068> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_107069>."
25, Reduction, 1507, 1512, "7 . 2", "", "<http://ctro/data#Outcome_107073> <http://ctro/data#hasChangeValue> \"7 . 2\"."
26, SdDevChangeValue, 1519, 1524, "3 . 2", "", "<http://ctro/data#Outcome_107073> <http://ctro/data#hasSdDevChangeValue> \"3 . 2\"."
27, mmHg, 1525, 1530, "mm Hg", "", "<http://ctro/data#Endpoint_107068> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
28, RelativeReduction, 1533, 1535, "28", "", "<http://ctro/data#Outcome_107073> <http://ctro/data#hasRelativeChangeValue> \"28\"."
75, Latanoprost, 1544, 1555, "latanoprost", "", 
29, BaseLineValue, 1558, 1564, "25 . 3", "", "<http://ctro/data#Outcome_107073> <http://ctro/data#hasBaselineValue> \"25 . 3\"."
30, SdDevBL, 1571, 1576, "2 . 8", "", "<http://ctro/data#Outcome_107073> <http://ctro/data#hasSdDevBL> \"2 . 8\"."
31, mmHg, 1577, 1582, "mm Hg", "", 
183, TimePoint, 1586, 1594, "baseline", "", 
32, ResultMeasuredValue, 1598, 1604, "18 . 2", "", "<http://ctro/data#Outcome_107073> <http://ctro/data#hasResultMeasuredValue> \"18 . 2\"."
33, SdDevResValue, 1611, 1616, "2 . 8", "", "<http://ctro/data#Outcome_107073> <http://ctro/data#hasSdDevResValue> \"2 . 8\"."
34, mmHg, 1617, 1622, "mm Hg", "", 
161, TimePoint, 1626, 1633, "8 weeks", "", "<http://ctro/data#Outcome_107073> <http://ctro/data#hasTimePoint> \"8 weeks\"."
35, Reduction, 1642, 1647, "3 . 9", "", "<http://ctro/data#Outcome_107100> <http://ctro/data#hasChangeValue> \"3 . 9\"."
36, SdDevChangeValue, 1654, 1659, "2 . 6", "", "<http://ctro/data#Outcome_107100> <http://ctro/data#hasSdDevChangeValue> \"2 . 6\"."
37, mmHg, 1660, 1665, "mm Hg", "", 
38, RelativeReduction, 1668, 1670, "15", "", "<http://ctro/data#Outcome_107100> <http://ctro/data#hasRelativeChangeValue> \"15\"."
76, Unoprostone, 1679, 1690, "unoprostone", "", 
39, BaseLineValue, 1693, 1699, "25 . 5", "", "<http://ctro/data#Outcome_107100> <http://ctro/data#hasBaselineValue> \"25 . 5\"."
40, SdDevBL, 1706, 1711, "3 . 3", "", "<http://ctro/data#Outcome_107100> <http://ctro/data#hasSdDevBL> \"3 . 3\"."
41, mmHg, 1712, 1717, "mm Hg", "", 
41687, TimePoint, 1721, 1729, "baseline", "", 
42, ResultMeasuredValue, 1733, 1739, "21 . 6", "", "<http://ctro/data#Outcome_107100> <http://ctro/data#hasResultMeasuredValue> \"21 . 6\"."
43, SdDevResValue, 1746, 1751, "4 . 0", "", "<http://ctro/data#Outcome_107100> <http://ctro/data#hasSdDevResValue> \"4 . 0\"."
44, mmHg, 1752, 1757, "mm Hg", "", 
163, PvalueDiff, 1760, 1774, "P < or = . 001", "", "<http://ctro/data#DiffBetweenGroups_107127> <http://ctro/data#hasPvalueDiff> \"P < or = . 001\"."
164, ObservedResult, 1777, 1843, "No serious adverse event related to either medication was reported", "", "<http://ctro/data#Outcome_107141> <http://ctro/data#hasObservedResult> \"No serious adverse event related to either medication was reported\". <http://ctro/data#Outcome_107168> <http://ctro/data#hasObservedResult> \"No serious adverse event related to either medication was reported\"."
41709, EndPointDescription, 1788, 1801, "adverse event", "", "<http://ctro/data#EndPointDescription_107137> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_107136> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_107137>."
47, ConclusionComment, 1860, 2005, "Over an 8 - week period , latanoprost 0 . 005 % once daily lowered IOP more than unoprostone 0 . 15 % twice daily in patients with elevated IOP .", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasConclusionComment> \"Over an 8 - week period , latanoprost 0 . 005 % once daily lowered IOP more than unoprostone 0 . 15 % twice daily in patients with elevated IOP .\"."
77, Duration, 1868, 1876, "8 - week", "", 
78, Latanoprost, 1886, 1897, "latanoprost", "", 
80, DoseValue, 1898, 1905, "0 . 005", "", 
82, Percentage, 1906, 1907, "%", "", 
84, Frequency, 1908, 1918, "once daily", "", 
49, IOP, 1927, 1930, "IOP", "", 
79, Unoprostone, 1941, 1952, "unoprostone", "", 
81, DoseValue, 1953, 1959, "0 . 15", "", 
83, Percentage, 1960, 1961, "%", "", 
85, Frequency, 1962, 1973, "twice daily", "", 
50, IOP, 2000, 2003, "IOP", "", 
48, ConclusionComment, 2006, 2048, "Both agents were safe and well tolerated .", "", "<http://ctro/data#ClinicalTrial_106988> <http://ctro/data#hasConclusionComment> \"Both agents were safe and well tolerated .\"."
51, PMID, 2104, 2112, "12470755", "", "<http://ctro/data#Publication_103776> <http://ctro/data#hasPMID> \"12470755\"."
